Search results for "Early detection"

showing 10 items of 222 documents

Cancer: New Needs, New Models. Is It Time for a Community Oncologist? Another Brick in the Wall

2021

Simple Summary Community care activity in the oncology field does not exist. This unmet need contrasts with the increasing number of patients with a previous diagnosis of cancer. Abstract Over the last few decades, thanks to early detection, effective drugs, and personalized treatments, the natural history of cancer has radically changed. Thanks to these advances, we have observed how survival of cancer patients has increased, becoming an ever more important goal in cancer care. Effective clinical governance of survivorship care is essential to ensure a successful transition between active and post-treatment life, identifying optimization of healthcare outcomes and quality of life for patie…

OncologyCancer Researchmedicine.medical_specialtySettore MED/06 - Oncologia MedicaEarly detectionSettore MED/42 - Igiene Generale E Applicataclinical governance03 medical and health sciences0302 clinical medicineQuality of life (healthcare)Internal medicineSurvivorship curveIntervention (counseling)Health caremedicine030212 general & internal medicineRC254-282Clinical governancebusiness.industryCancerNeoplasms. Tumors. Oncology. Including cancer and carcinogensmedicine.diseasecommunity oncologyNatural historycancer survivorshipOncology030220 oncology & carcinogenesisPerspectivebusinessPsychologyCancers
researchProduct

Circulating miR-30b-5p levels in plasma as a novel potential biomarker for early detection of breast cancer

2021

Background Recently, microRNAs have been demonstrated to be potential non-invasive biomarkers for diagnosis, prognosis assessment or prediction of response to treatment in cancer. In this study, we evaluate the potential of miR-30b-5p as a biomarker for early diagnosis of breast cancer (BC) in tissue and plasma. Methods Expression of miR-30b-5p was determined in a series of 112 BC and 40 normal breast tissues. Circulating miR-30b-5p levels in plasma samples were determined in a discovery cohort of 38 BC patients and 40 healthy donors and in a validation cohort of 83 BC patients and 83 healthy volunteers. miR-30b-5p expression was measured by quantitative real-time PCR and receiver operating…

OncologyCancer Researchmedicine.medical_specialtydiagnosisBreast NeoplasmsBreast cancerbreast cancerPositive axillary lymph nodeInternal medicinemicroRNAmedicineBiomarkers TumorHumansStage (cooking)plasmaEarly Detection of CancerOriginal ResearchReceiver operating characteristicmicroRNAbusiness.industryCancermedicine.diseasePrognosisMicroRNAsOncologyCohortBiomarker (medicine)FemalebusinessESMO Open
researchProduct

Intrahepatic Chemotherapy in Isolated Liver Metastases

1983

Most malignant liver tumors in Europe are of metastatic origin. The failure of early detection renders most of these tumors nonresectable at the time of diagnosis.

OncologyIsolated liverVincristinemedicine.medical_specialtyCarmustineChemotherapybusiness.industryDacarbazinemedicine.medical_treatmentEarly detectionGastroenterologyFloxuridineFluorouracilInternal medicinemedicinebusinessmedicine.drug
researchProduct

A Tetra-Panel of Serum Circulating miRNAs for the Diagnosis of the Four Most Prevalent Tumor Types

2020

The purpose of this study is to clinically validate a series of circulating miRNAs that distinguish between the 4 most prevalent tumor types (lung cancer (LC)

OncologyMaleLung NeoplasmsColorectal cancerlcsh:ChemistryProstate cancer0302 clinical medicinelcsh:QH301-705.5SpectroscopyEarly Detection of CancerAged 80 and over0303 health sciencesArea under the curveGeneral MedicineMiddle AgedEarly diagnosisprostate cancer3. Good healthComputer Science Applications030220 oncology & carcinogenesisArea Under CurveFemaleColorectal NeoplasmsAdultmedicine.medical_specialtyBreast Neoplasmscolorectal cancerCatalysisArticleInorganic Chemistry03 medical and health sciencesBreast cancerbreast cancerInternal medicinemedicineHumansCirculating MicroRNAPhysical and Theoretical ChemistryLung cancerMolecular Biology030304 developmental biologyAgedNeoplasm StagingReceiver operating characteristicbusiness.industryOrganic ChemistryCancerProstatic Neoplasmsmedicine.diseaseCirculating MicroRNAlung cancerlcsh:Biology (General)lcsh:QD1-999ROC CurveCase-Control StudiesMultivariate Analysiscirculating microRNAsbusinessInternational Journal of Molecular Sciences
researchProduct

Improving uptake of screening for colorectal cancer: a study on invitation strategies and different test kit use

2015

Objective The aim of this study was to compare the uptake of mail-delivered tests for colorectal cancer screening. We assessed the effect of an advance notification letter and a reminder letter, and analysed the proportion of inappropriately handled tests. Materials and methods Fifteen thousand randomly selected residents of Latvia aged 50–74 years were allocated to receive one of three different test systems: either a guaiac faecal occult blood test (gFOBT) or one of two laboratory-based immunochemical tests (FIT) – FOB Gold or OC-Sensor. Half of the target population received an advance notification letter; all nonresponders were sent a reminder letter. Results The uptake of screening was…

OncologyMalemedicine.medical_specialtygenetic structuresColorectal cancerReminder Systemseducationcolorectal cancer screeningfaecal occult blood testSpecimen HandlingRandom AllocationInternal medicinemedicinePostal serviceOriginal Articles: Colorectal CancerHumansPostal ServiceEarly Detection of CancerAgedRandom allocationGynecologyHepatologybusiness.industryImmunochemistryGastroenterologyMiddle AgedPatient Acceptance of Health Caremedicine.diseasefaecal immunochemical testCorrespondence as TopicLatviaadvance notification letterTest (assessment)Colorectal cancer screeninguptakeOccult BloodFemaleFaecal occult blood testbusinessColorectal NeoplasmsGuaiacEuropean Journal of Gastroenterology & Hepatology
researchProduct

Multidisciplinary strategies to improve treatment outcomes in hepatocellular carcinoma

2013

Hepatocellular carcinoma (HCC) is a complex disease with a poor prognosis. Incidence and mortality rates are increasing in many geographical regions, indicating a need for better management strategies. Among several risk factors for HCC, the most common are cirrhosis because of chronic hepatitis B virus or hepatitis C virus infection and alcohol consumption, obesity, and diabetes. In some patients, combined risk factors present additional challenges to the prevention and treatment of HCC. Screening and surveillance of high-risk populations varies widely by geographic regions, and access to optimal surveillance is critical for early diagnosis. The treatment choice for HCC depends on the canc…

OncologySorafenibmedicine.medical_specialtyCarcinoma Hepatocellularmedicine.medical_treatmentLiver transplantationInternal medicineHepatectomyHumansMedicineChemoembolization TherapeuticPrecision MedicineEarly Detection of CancerNeoplasm StagingHepatologybusiness.industryClinical study designLiver NeoplasmsGastroenterologymedicine.diseaseCombined Modality Therapydigestive system diseasesLiver TransplantationClinical trialTransplantationTreatment OutcomeHepatocellular carcinomaCatheter AblationLiver functionPersonalized medicinebusinessmedicine.drugEuropean Journal of Gastroenterology & Hepatology
researchProduct

Breath testing as a method for detecting lung cancer

2014

Early diagnosis of lung cancer is important due to high mortality in late stages of the disease. An ideal approach for population screening could be the breath analysis, due to its non-invasiveness, simplicity and cheapness. Using sensitive methods of analysis like gas chromatography/mass spectrometry in exhaled air of cancer patients were discovered some volatile organic compounds - possible candidates for cancer markers. However, these compounds were not specific for cancer cells. At the same time, integrative approaches used to analyze the exhaled breath have demonstrated high sensitivity and specificity of this method for lung cancer diagnosis. Such integrative approaches include detect…

Oncologyelectronic nosemedicine.medical_specialtyPathologyLung Neoplasms:MEDICINE [Research Subject Categories]Sensitivity and SpecificityGas Chromatography-Mass SpectrometryBreath testingInternal medicineCancer screeningBiomarkers TumormedicineHumansPharmacology (medical)Lung cancerEarly Detection of CancerNeoplasm StagingVolatile Organic CompoundsElectronic nosecancer diagnosticsbusiness.industryCancerExhalationexhaled breath analysismedicine.diseaselung cancerBreath TestsOncologyBreath gas analysisExhalationcancer screeningGas chromatographybusiness
researchProduct

Detection methods predict differences in biology and survival in breast cancer patients

2012

Abstract Background The aim of this study was to measure the biological characteristics involved in tumorigenesis and the progression of breast cancer in symptomatic and screen-detected carcinomas to identify possible differences. Methods For this purpose, we evaluated clinical-pathological parameters and proliferative and apoptotic activities in a series of 130 symptomatic and 161 screen-detected tumors. Results After adjustment for the smaller size of the screen-detected carcinomas compared with symptomatic cancers, those detected in the screening program presented longer disease-free survival (RR = 0.43, CI = 0.19-0.96) and had high estrogen and progesterone receptor concentrations more …

Oncologymedicine.medical_specialtyCancer ResearchSurvivalProliferationBreast NeoplasmsApoptosisKaplan-Meier Estimatemedicine.disease_causelcsh:RC254-282Breast cancerBreast cancerSurgical oncologyInternal medicineDetection methodsmedicineGeneticsHumansMammographyEarly Detection of CancerProportional Hazards Modelsmedicine.diagnostic_testbusiness.industryProportional hazards modelDisease progressionCase-control studyMiddle Agedlcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensPrognosismedicine.diseaseImmunohistochemistryOncologyCase-Control StudiesDisease ProgressionImmunohistochemistryFemalebusinessCarcinogenesisMammographyResearch Article
researchProduct

Early Detection of Cardiac Damage

2018

Early detection and quantification of cardiac damage in cancer patients are essential to readily intervene with cardioprotective strategies and avoid the need of the discontinuation of antineoplastic treatment.

Oncologymedicine.medical_specialtyCardiotoxicitybusiness.industryInternal medicinemedicineEarly detectionCancerbusinessmedicine.diseaseDiscontinuation
researchProduct

Primary colon cancer: ESMO Clinical Practice Guidelines for diagnosis, adjuvant treatment and follow-up.

2010

Oncologymedicine.medical_specialtyColorectal cancermedicine.medical_treatmentColonoscopyPharmacotherapyMeta-Analysis as TopicRisk FactorsInternal medicineEpidemiologyAntineoplastic Combined Chemotherapy ProtocolsmedicineSecondary PreventionHumansSurvival analysisEarly Detection of CancerNeoplasm StagingRandomized Controlled Trials as TopicChemotherapymedicine.diagnostic_testbusiness.industryIncidenceCancerHematologyColonoscopymedicine.diseasePrognosisSurvival AnalysisSurgeryCarcinoembryonic AntigenEuropeTreatment OutcomeOncologyChemotherapy AdjuvantColonic NeoplasmsbusinessAdjuvantFollow-Up StudiesAnnals of oncology : official journal of the European Society for Medical Oncology
researchProduct